Becton Dickinson & Co. (BDX): Price and Financial Metrics


Becton Dickinson & Co. (BDX): $233.92

-3.27 (-1.38%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BDX POWR Grades

  • Stability is the dimension where BDX ranks best; there it ranks ahead of 90.52% of US stocks.
  • The strongest trend for BDX is in Stability, which has been heading up over the past 178 days.
  • BDX ranks lowest in Momentum; there it ranks in the 29th percentile.

BDX Stock Summary

  • BECTON DICKINSON & CO's market capitalization of $73,209,585,250 is ahead of 97.1% of US-listed equities.
  • BECTON DICKINSON & CO's stock had its IPO on January 1, 1986, making it an older stock than 93.26% of US equities in our set.
  • The volatility of BECTON DICKINSON & CO's share price is greater than that of just 1.99% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to BECTON DICKINSON & CO, a group of peers worth examining would be ZTS, MMM, SYK, BSX, and ABB.
  • BDX's SEC filings can be seen here. And to visit BECTON DICKINSON & CO's official web site, go to www.bd.com.

BDX Valuation Summary

  • BDX's EV/EBIT ratio is 38.3; this is 270.05% higher than that of the median Healthcare stock.
  • Over the past 243 months, BDX's price/earnings ratio has gone up 27.6.

Below are key valuation metrics over time for BDX.

Stock Date P/S P/B P/E EV/EBIT
BDX 2022-09-09 3.8 2.9 45.0 38.3
BDX 2022-09-08 3.8 2.9 44.6 38.0
BDX 2022-09-07 3.7 2.9 44.3 37.8
BDX 2022-09-06 3.6 2.8 43.2 36.9
BDX 2022-09-02 3.6 2.8 43.3 37.0
BDX 2022-09-01 3.7 2.9 43.7 37.3

BDX Growth Metrics

    The year over year net cashflow from operations growth rate now stands at -39.89%.
  • The year over year net income to common stockholders growth rate now stands at 11.59%.
  • Its 5 year price growth rate is now at 52.1%.
BDX's revenue has moved up $7,299,000,000 over the prior 70 months.

The table below shows BDX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 19,782 2,612 1,666
2022-03-31 20,031 3,044 1,830
2021-12-31 19,927 3,788 1,676
2021-09-30 20,248 4,647 2,002
2021-06-30 19,896 5,177 1,865
2021-03-31 18,861 5,064 1,640

BDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BDX has a Quality Grade of C, ranking ahead of 56.62% of graded US stocks.
  • BDX's asset turnover comes in at 0.365 -- ranking 118th of 186 Medical Equipment stocks.
  • MYO, BTCY, and NURO are the stocks whose asset turnover ratios are most correlated with BDX.

The table below shows BDX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.365 0.470 0.103
2021-03-31 0.347 0.469 0.092
2020-12-31 0.337 0.458 0.088
2020-09-30 0.321 0.443 0.059
2020-06-30 0.320 0.451 0.053
2020-03-31 0.333 0.462 0.062

BDX Price Target

For more insight on analysts targets of BDX, see our BDX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $267.80 Average Broker Recommendation 1.58 (Moderate Buy)

BDX Stock Price Chart Interactive Chart >

Price chart for BDX

BDX Price/Volume Stats

Current price $233.92 52-week high $280.62
Prev. close $237.19 52-week low $230.62
Day low $230.62 Volume 1,440,000
Day high $237.33 Avg. volume 1,158,055
50-day MA $251.99 Dividend yield 1.49%
200-day MA $255.77 Market Cap 66.71B

Becton Dickinson & Co. (BDX) Company Bio


Becton, Dickinson and Company provides solutions which are focused on improving medication management and patient safety, supporting infection prevention practices, equipping surgical and interventional procedures, improving drug delivery, aiding anesthesiology and respiratory care, advancing cellular research and applications, enhancing the diagnosis of infectious diseases and cancers, and supporting the management of diabetes. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.


BDX Latest News Stream


Event/Time News Detail
Loading, please wait...

BDX Latest Social Stream


Loading social stream, please wait...

View Full BDX Social Stream

Latest BDX News From Around the Web

Below are the latest news stories about BECTON DICKINSON & CO that investors may wish to consider to help them evaluate BDX as an investment opportunity.

2 Top Dividend Kings to Buy for the Long Haul

Johnson & Johnson (NYSE: JNJ) and Becton, Dickinson (NYSE: BDX) are set-it-and-forget-it dividend stocks in the healthcare sector. For example, in the second quarter, the company's pharmaceutical segment was responsible for $13.3 billion in revenue, up 6.7%, year over year, while consumer healthcare brought in $3.8 billion, down 1.3% over the same period in 2021.

Yahoo | September 21, 2022

Insiders probably made the right decision selling US$1.1m worth of shares earlier this year as Becton, Dickinson and Company's (NYSE:BDX)) stock dips by 4.9%.

Insiders seem to have made the most of their holdings by selling US$1.1m worth of Becton, Dickinson and Company...

Yahoo | September 20, 2022

BD's (BDX) Latest PFS Launch to Boost Production Efficiencies

BD's (BDX) newest product offering is expected to set a new standard in performance for vaccine PFS with new and strict specifications for improved production efficiencies.

Yahoo | September 14, 2022

Implied Volatility Surging for BD (BDX) Stock Options

Investors need to pay close attention to BD (BDX) stock based on the movements in the options market lately.

Yahoo | September 13, 2022

BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity.1

Yahoo | September 13, 2022

Read More 'BDX' Stories Here

BDX Price Returns

1-mo -7.50%
3-mo -6.15%
6-mo -10.46%
1-year -3.94%
3-year -0.32%
5-year 31.84%
YTD -3.63%
2021 1.88%
2020 -6.75%
2019 22.20%
2018 6.61%
2017 31.24%

BDX Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BDX Dividend History

Continue Researching BDX

Here are a few links from around the web to help you further your research on Becton Dickinson & Co's stock as an investment opportunity:

Becton Dickinson & Co (BDX) Stock Price | Nasdaq
Becton Dickinson & Co (BDX) Stock Quote, History and News - Yahoo Finance
Becton Dickinson & Co (BDX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5456 seconds.